Figure 6
Figure 6. Tissue-specific generation of pDCs or cDC subpopulations on day 7 after transfer. (A) CD45.2+CCR9− pDC-like precursors were transferred into CD45.1+ steady-state mice intravenously and progeny were analyzed 7 days later by flow cytometry for the expression of BST2, CD11b, CD8α, and CD103 in BM, spleen, lung, and liver. Results of one representative of 3 experiments are shown. (B) The percentages of BST2+ pDCs and BST2− cDCs within CD45.2+CD11c+MHCII+PI− cells derived from transferred CCR9− pDC-like precursors after 7 days in BM, spleen, lung, and liver (mean ± SD, n = 3). (C) cDC subset compositions (CD8α+CD11b− cDCs, CD8α−CD11b+ cDCs, and double negative cDCs) in spleen and lung originating from CD45.2+CCR9− pDC-like precursors 7 days after transfer are depicted (mean, n = 3).

Tissue-specific generation of pDCs or cDC subpopulations on day 7 after transfer. (A) CD45.2+CCR9 pDC-like precursors were transferred into CD45.1+ steady-state mice intravenously and progeny were analyzed 7 days later by flow cytometry for the expression of BST2, CD11b, CD8α, and CD103 in BM, spleen, lung, and liver. Results of one representative of 3 experiments are shown. (B) The percentages of BST2+ pDCs and BST2 cDCs within CD45.2+CD11c+MHCII+PI cells derived from transferred CCR9 pDC-like precursors after 7 days in BM, spleen, lung, and liver (mean ± SD, n = 3). (C) cDC subset compositions (CD8α+CD11b cDCs, CD8αCD11b+ cDCs, and double negative cDCs) in spleen and lung originating from CD45.2+CCR9 pDC-like precursors 7 days after transfer are depicted (mean, n = 3).

Close Modal

or Create an Account

Close Modal
Close Modal